Advertisement
Advertisement
TPST
Tempest Therapeutics, Inc. Common Stock
0.37
USDSponsored
+0.01
+3.54%
Nov 10, 15:48 UTC -5
Closed
After-Market
0.37
0.00
-0.86%
Tempest Therapeutics, Inc. Common Stock (TPST) Earnings
TPST Earnings Reports
Positive Surprise Ratio
TPST beat 22 of 40 last estimates.
55%
Next Report
Date of Next Report
Mar 29, 2027
Estimate for Q4 26 (Revenue/ EPS)
--
/-$0.29
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/-53.23%
Tempest Therapeutics, Inc. Common Stock earnings per share and revenue
On Nov 03, 2026, TPST reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.32 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.13% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Definium Therapeutics, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.56
Actual
-$0.46
Surprise
+19.06%
Ocular Therapeutix, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.36
Actual
-$0.42
Surprise
-13.54%
Harrow, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.22
Actual
$0.12
Surprise
-45.92%
SIGA Technologies Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-Actual
-$0.04
Surprise
-
Protara Therapeutics, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.35
Surprise
+6.17%
Minerva Neurosciences, Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.12
Actual
$1.94
Surprise
+1,629.97%
Tonix Pharmaceuticals Holding Corp.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$2.40
Actual
-$2.89
Surprise
-20.23%
Cumberland Pharmaceuticals Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-Actual
-$0.07
Surprise
-
PMV Pharmaceuticals, Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Corbus Pharmaceuticals Holdings, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.23
Actual
-$1.81
Surprise
-46.07%
FAQ
What were Tempest Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Tempest Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Tempest Therapeutics, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -1.13%, changed from $0.47 before the earnings release to $0.46 the day after.
When is Tempest Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 29, 2027.
What are the forecasts for Tempest Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Tempest Therapeutics, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.